White & Case Guides Life Sciences SPAC To $385M IPO
A special purpose acquisition company focused on life sciences started trading Wednesday after pricing an upsized, $385 million initial public offering guided by White & Case LLP....To view the full article, register now.
Already a subscriber? Click here to view full article